Intracardiac Echocardiography Guided Watchman Device Implant

Description

This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.

Conditions

Atrial Fibrillation, Left Atrial Appendage Thrombosis

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is to look at the success of Intracardiac Echocardiography (ICE) in the Watchman procedure. Currently the process is to use a Transesophageal Echocardiography (TEE) to place the Watchman in patients. This study is aiming to show how the ICE is just as effective in placing the device correctly and effectively.

Feasibility: Intracardiac Echocardiography Guided Watchman Device Implant

Intracardiac Echocardiography Guided Watchman Device Implant

Condition
Atrial Fibrillation
Intervention / Treatment

-

Contacts and Locations

Cleveland

Cleveland Clinic, Cleveland, Ohio, United States, 44195

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * All patients who meet guideline established criteria for commercially available Watchman device implant and not enrolled in an active clinical trial
  • * Patients in whom a procedural TEE cannot be performed and an ICE only implant is needed.
  • * Patients receiving a concomitant ablation procedure
  • * Patients with prior incomplete surgical or percutaneous left atrial appendage ligation/exclusion procedures
  • * Patients in whom the delivery of trans-septal equipment is anticipated to be difficult (e.g. patent foramen ovale (PFO) or atrial septal defect (ASD) closure devices in place).

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Cleveland Clinic,

Shady Nakhla, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic

Study Record Dates

2026-12-31